| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cargo receptor activity | 2.62e-05 | 85 | 137 | 6 | GO:0038024 | |
| GeneOntologyMolecularFunction | glutamine-fructose-6-phosphate transaminase (isomerizing) activity | 4.67e-05 | 2 | 137 | 2 | GO:0004360 | |
| GeneOntologyMolecularFunction | D-dopachrome decarboxylase activity | 4.67e-05 | 2 | 137 | 2 | GO:0033981 | |
| GeneOntologyMolecularFunction | phenylpyruvate tautomerase activity | 1.40e-04 | 3 | 137 | 2 | GO:0050178 | |
| GeneOntologyMolecularFunction | L-glutamine aminotransferase activity | 1.40e-04 | 3 | 137 | 2 | GO:0070548 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 2.47e-04 | 180 | 137 | 7 | GO:0004866 | |
| GeneOntologyMolecularFunction | protease binding | 2.56e-04 | 181 | 137 | 7 | GO:0002020 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, interconverting keto- and enol-groups | 2.78e-04 | 4 | 137 | 2 | GO:0016862 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 3.12e-04 | 187 | 137 | 7 | GO:0030414 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 4.81e-04 | 201 | 137 | 7 | GO:0061135 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 7.88e-04 | 105 | 137 | 5 | GO:0004867 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 1.64e-05 | 48 | 137 | 5 | GO:0043277 | |
| GeneOntologyBiologicalProcess | UDP-N-acetylglucosamine biosynthetic process | 2.34e-05 | 9 | 137 | 3 | GO:0006048 | |
| GeneOntologyBiologicalProcess | amino sugar biosynthetic process | 4.55e-05 | 11 | 137 | 3 | GO:0046349 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 5.81e-05 | 321 | 137 | 10 | GO:0099003 | |
| GeneOntologyBiologicalProcess | import into cell | HSPG2 HIP1 GAS6 HEATR5A CUBN AP3M1 SLC1A4 OPHN1 ARG2 KCNJ8 SLC27A1 AP3M2 LRP1 LRP6 C4A C4B ATP1A3 MARCO WNK2 | 9.02e-05 | 1074 | 137 | 19 | GO:0098657 |
| GeneOntologyBiologicalProcess | UDP-N-acetylglucosamine metabolic process | 9.89e-05 | 14 | 137 | 3 | GO:0006047 | |
| GeneOntologyBiologicalProcess | negative regulation of protein metabolic process | HSPG2 FLOT2 TRIM2 GAS6 IREB2 LRRK1 TRIM3 OPHN1 PLAA PTPRH SERPINB12 A2ML1 TMEM132A LRP1 LRP6 SERPINC1 CDH1 SERPIND1 PML | 1.07e-04 | 1088 | 137 | 19 | GO:0051248 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 1.14e-04 | 164 | 137 | 7 | GO:0099072 | |
| GeneOntologyCellularComponent | microvillus membrane | 4.91e-06 | 38 | 138 | 5 | GO:0031528 | |
| GeneOntologyCellularComponent | axon | SETX DSCAM PCLO SLC5A7 IREB2 NFASC AP3M1 OPHN1 AP3M2 LRP1 NAV1 C4A RIMBP2 C4B VSTM5 ATP1A3 CDH1 USH2A NIN | 6.45e-06 | 891 | 138 | 19 | GO:0030424 |
| GeneOntologyCellularComponent | microvillus | 1.76e-05 | 123 | 138 | 7 | GO:0005902 | |
| GeneOntologyCellularComponent | dendrite | FLOT2 CTTNBP2 DSCAM PCLO SLC5A7 NFASC SLC1A4 TRIM3 OPHN1 TP63 LRP1 C4A C4B VSTM5 ATP1A3 EPHA10 NIN | 5.18e-05 | 858 | 138 | 17 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | FLOT2 CTTNBP2 DSCAM PCLO SLC5A7 NFASC SLC1A4 TRIM3 OPHN1 TP63 LRP1 C4A C4B VSTM5 ATP1A3 EPHA10 NIN | 5.34e-05 | 860 | 138 | 17 | GO:0097447 |
| GeneOntologyCellularComponent | catenin complex | 5.66e-05 | 32 | 138 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | actin-based cell projection | 9.83e-05 | 278 | 138 | 9 | GO:0098858 | |
| GeneOntologyCellularComponent | anchoring collagen complex | 1.29e-04 | 3 | 138 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | somatodendritic compartment | FLOT2 CTTNBP2 DSCAM PCLO SLC5A7 IREB2 NFASC SLC1A4 TRIM3 OPHN1 TP63 LRP1 LRP6 C4A C4B VSTM5 ATP1A3 USH2A EPHA10 NIN | 1.64e-04 | 1228 | 138 | 20 | GO:0036477 |
| GeneOntologyCellularComponent | glutamatergic synapse | FLOT2 HIP1 CTTNBP2 PCLO IQSEC2 ACTR3 TRIM3 OPHN1 CADPS KCNJ8 AP3M2 LRP1 RIMBP2 CADPS2 CDH1 | 3.33e-04 | 817 | 138 | 15 | GO:0098978 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 4.53e-04 | 23 | 138 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | apical part of cell | FLOT2 VASH1 SLC5A7 CDH23 CUBN PTPRH LRP1 UPK2 CDH1 USH2A MUC4 NIN | 5.68e-04 | 592 | 138 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | distal axon | 6.36e-04 | 435 | 138 | 10 | GO:0150034 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 6.38e-04 | 6 | 138 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | presynapse | FLOT2 HIP1 CTTNBP2 PCLO IQSEC2 SLC5A7 OPHN1 CADPS KCNJ8 AP3M2 RIMBP2 ATP1A3 CADPS2 CDH1 USH2A | 7.71e-04 | 886 | 138 | 15 | GO:0098793 |
| GeneOntologyCellularComponent | symbiont cell surface | 1.18e-03 | 8 | 138 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | ribbon synapse | 1.21e-03 | 32 | 138 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | other organism part | 1.51e-03 | 9 | 138 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.66e-03 | 332 | 138 | 8 | GO:0005788 | |
| GeneOntologyCellularComponent | flotillin complex | 1.88e-03 | 10 | 138 | 2 | GO:0016600 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | IL12RB1 HSPG2 FLOT2 CDH23 AHNAK KCNJ8 LRP1 LRP6 ATP1A3 CDH1 CDH5 CDH17 KCNH5 | 2.11e-03 | 785 | 138 | 13 | GO:0098797 |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 2.17e-03 | 137 | 138 | 5 | GO:0019897 | |
| GeneOntologyCellularComponent | presynaptic active zone | 2.46e-03 | 141 | 138 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | blood microparticle | 2.69e-03 | 144 | 138 | 5 | GO:0072562 | |
| GeneOntologyCellularComponent | axon terminus | 2.74e-03 | 210 | 138 | 6 | GO:0043679 | |
| GeneOntologyCellularComponent | plasma membrane raft | 2.94e-03 | 147 | 138 | 5 | GO:0044853 | |
| GeneOntologyCellularComponent | AP-3 adaptor complex | 3.22e-03 | 13 | 138 | 2 | GO:0030123 | |
| GeneOntologyCellularComponent | cell cortex region | 3.26e-03 | 45 | 138 | 3 | GO:0099738 | |
| Domain | fn3 | IL12RB1 COL12A1 MYLK DSCAM NFASC PTPRH COL14A1 RIMBP2 ROS1 USH2A EPHA10 | 2.44e-08 | 162 | 134 | 11 | PF00041 |
| Domain | FN3 | IL12RB1 COL12A1 MYLK DSCAM NFASC PTPRH COL14A1 RIMBP2 ROS1 USH2A EPHA10 | 9.55e-08 | 185 | 134 | 11 | SM00060 |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.73e-07 | 8 | 134 | 4 | IPR019565 | |
| Domain | Thiol-ester_cl | 1.73e-07 | 8 | 134 | 4 | PF10569 | |
| Domain | MacrogloblnA2_CS | 1.73e-07 | 8 | 134 | 4 | IPR019742 | |
| Domain | FN3 | IL12RB1 COL12A1 MYLK DSCAM NFASC PTPRH COL14A1 RIMBP2 ROS1 USH2A EPHA10 | 2.00e-07 | 199 | 134 | 11 | PS50853 |
| Domain | FN3_dom | IL12RB1 COL12A1 MYLK DSCAM NFASC PTPRH COL14A1 RIMBP2 ROS1 USH2A EPHA10 | 3.27e-07 | 209 | 134 | 11 | IPR003961 |
| Domain | - | 3.27e-07 | 39 | 134 | 6 | 2.120.10.30 | |
| Domain | A2M | 5.15e-07 | 10 | 134 | 4 | PF00207 | |
| Domain | A2M_N_2 | 5.15e-07 | 10 | 134 | 4 | IPR011625 | |
| Domain | A2M_comp | 5.15e-07 | 10 | 134 | 4 | IPR011626 | |
| Domain | A2M_recep | 5.15e-07 | 10 | 134 | 4 | PF07677 | |
| Domain | A2M_comp | 5.15e-07 | 10 | 134 | 4 | PF07678 | |
| Domain | A2M_N | 5.15e-07 | 10 | 134 | 4 | PF01835 | |
| Domain | A2M_N | 5.15e-07 | 10 | 134 | 4 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 5.15e-07 | 10 | 134 | 4 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 5.15e-07 | 10 | 134 | 4 | PS00477 | |
| Domain | A2M_N_2 | 5.15e-07 | 10 | 134 | 4 | PF07703 | |
| Domain | Macroglobln_a2 | 5.15e-07 | 10 | 134 | 4 | IPR001599 | |
| Domain | 6-blade_b-propeller_TolB-like | 9.02e-07 | 46 | 134 | 6 | IPR011042 | |
| Domain | Ig-like_fold | IL12RB1 HSPG2 COL12A1 TRIM2 MYLK DSCAM VTCN1 NFASC TRIM3 PTPRH PIGR COL14A1 RIMBP2 ROS1 FGFR3 VSTM5 USH2A EPHA10 | 3.03e-06 | 706 | 134 | 18 | IPR013783 |
| Domain | VWF_type-D | 4.31e-06 | 16 | 134 | 4 | IPR001846 | |
| Domain | VWFD | 4.31e-06 | 16 | 134 | 4 | PS51233 | |
| Domain | VWD | 4.31e-06 | 16 | 134 | 4 | SM00216 | |
| Domain | VWD | 4.31e-06 | 16 | 134 | 4 | PF00094 | |
| Domain | - | IL12RB1 HSPG2 COL12A1 TRIM2 MYLK DSCAM VTCN1 NFASC TRIM3 PIGR COL14A1 RIMBP2 ROS1 FGFR3 VSTM5 USH2A EPHA10 | 5.42e-06 | 663 | 134 | 17 | 2.60.40.10 |
| Domain | Terpenoid_cyclase/PrenylTrfase | 7.17e-06 | 18 | 134 | 4 | IPR008930 | |
| Domain | A2M_N_2 | 1.97e-05 | 8 | 134 | 3 | SM01359 | |
| Domain | - | 1.97e-05 | 8 | 134 | 3 | 2.60.40.690 | |
| Domain | A2M_recep | 1.97e-05 | 8 | 134 | 3 | SM01361 | |
| Domain | A2M | 1.97e-05 | 8 | 134 | 3 | SM01360 | |
| Domain | NHL_repeat_subgr | 2.94e-05 | 9 | 134 | 3 | IPR013017 | |
| Domain | EGF | 3.47e-05 | 126 | 134 | 7 | PF00008 | |
| Domain | NHL_repeat | 4.18e-05 | 10 | 134 | 3 | IPR001258 | |
| Domain | NHL | 4.18e-05 | 10 | 134 | 3 | PF01436 | |
| Domain | CAPS | 5.11e-05 | 2 | 134 | 2 | IPR033227 | |
| Domain | GlmS_trans | 5.11e-05 | 2 | 134 | 2 | IPR005855 | |
| Domain | SIS | 5.11e-05 | 2 | 134 | 2 | PF01380 | |
| Domain | Laminin_G | 5.96e-05 | 58 | 134 | 5 | IPR001791 | |
| Domain | - | 7.58e-05 | 12 | 134 | 3 | 1.50.10.20 | |
| Domain | NHL | 9.80e-05 | 13 | 134 | 3 | PS51125 | |
| Domain | Ig_E-set | 1.04e-04 | 104 | 134 | 6 | IPR014756 | |
| Domain | Bod1-like | 1.53e-04 | 3 | 134 | 2 | IPR026955 | |
| Domain | Macrophage_inhib_fac | 1.53e-04 | 3 | 134 | 2 | PD004816 | |
| Domain | SIS | 1.53e-04 | 3 | 134 | 2 | PS51464 | |
| Domain | Macrophage_inhib_fac_CS | 1.53e-04 | 3 | 134 | 2 | IPR019829 | |
| Domain | Tautomerase/MIF_sf | 1.53e-04 | 3 | 134 | 2 | IPR014347 | |
| Domain | MIF | 1.53e-04 | 3 | 134 | 2 | PS01158 | |
| Domain | SIS | 1.53e-04 | 3 | 134 | 2 | IPR001347 | |
| Domain | Macrophage_inhib_fac | 1.53e-04 | 3 | 134 | 2 | IPR001398 | |
| Domain | MIF | 1.53e-04 | 3 | 134 | 2 | PF01187 | |
| Domain | LY | 1.54e-04 | 15 | 134 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.54e-04 | 15 | 134 | 3 | IPR000033 | |
| Domain | EGF | 2.98e-04 | 235 | 134 | 8 | SM00181 | |
| Domain | AMOP | 3.04e-04 | 4 | 134 | 2 | SM00723 | |
| Domain | AMOP | 3.04e-04 | 4 | 134 | 2 | PF03782 | |
| Domain | AMOP_dom | 3.04e-04 | 4 | 134 | 2 | IPR005533 | |
| Domain | AMOP | 3.04e-04 | 4 | 134 | 2 | PS50856 | |
| Domain | EGF-like_dom | 4.39e-04 | 249 | 134 | 8 | IPR000742 | |
| Domain | Quino_amine_DH_bsu | 5.03e-04 | 22 | 134 | 3 | IPR011044 | |
| Domain | Anaphylatoxin_comp_syst | 5.04e-04 | 5 | 134 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 5.04e-04 | 5 | 134 | 2 | IPR001840 | |
| Domain | GATASE_TYPE_2 | 5.04e-04 | 5 | 134 | 2 | PS51278 | |
| Domain | DUF1041 | 5.04e-04 | 5 | 134 | 2 | SM01145 | |
| Domain | GATase_2_dom | 5.04e-04 | 5 | 134 | 2 | IPR017932 | |
| Domain | EGF_1 | 5.13e-04 | 255 | 134 | 8 | PS00022 | |
| Domain | EGF-like_CS | 5.98e-04 | 261 | 134 | 8 | IPR013032 | |
| Domain | EGF_2 | 6.61e-04 | 265 | 134 | 8 | PS01186 | |
| Domain | Clathrin_mu_CS | 7.52e-04 | 6 | 134 | 2 | IPR018240 | |
| Domain | CLAT_ADAPTOR_M_1 | 7.52e-04 | 6 | 134 | 2 | PS00990 | |
| Domain | CLAT_ADAPTOR_M_2 | 7.52e-04 | 6 | 134 | 2 | PS00991 | |
| Domain | ANATO | 1.05e-03 | 7 | 134 | 2 | SM00104 | |
| Domain | Munc13_1 | 1.05e-03 | 7 | 134 | 2 | IPR014770 | |
| Domain | MHD1 | 1.05e-03 | 7 | 134 | 2 | PS51258 | |
| Domain | ANAPHYLATOXIN_2 | 1.05e-03 | 7 | 134 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 1.05e-03 | 7 | 134 | 2 | PS01177 | |
| Domain | DUF1041 | 1.05e-03 | 7 | 134 | 2 | PF06292 | |
| Domain | ANATO | 1.05e-03 | 7 | 134 | 2 | PF01821 | |
| Domain | CAPS_dom | 1.05e-03 | 7 | 134 | 2 | IPR010439 | |
| Domain | Anaphylatoxin/fibulin | 1.05e-03 | 7 | 134 | 2 | IPR000020 | |
| Domain | Serpin_CS | 1.54e-03 | 32 | 134 | 3 | IPR023795 | |
| Domain | EGF_3 | 1.55e-03 | 235 | 134 | 7 | PS50026 | |
| Domain | Ntn_hydrolases_N | 1.68e-03 | 33 | 134 | 3 | IPR029055 | |
| Domain | Serpin_dom | 2.17e-03 | 36 | 134 | 3 | IPR023796 | |
| Domain | IG_FLMN | 2.21e-03 | 10 | 134 | 2 | SM00557 | |
| Domain | Clathrin_mu | 2.21e-03 | 10 | 134 | 2 | IPR001392 | |
| Domain | SERPIN | 2.35e-03 | 37 | 134 | 3 | PS00284 | |
| Domain | SERPIN | 2.35e-03 | 37 | 134 | 3 | SM00093 | |
| Domain | Serpin | 2.54e-03 | 38 | 134 | 3 | PF00079 | |
| Domain | LAM_G_DOMAIN | 2.54e-03 | 38 | 134 | 3 | PS50025 | |
| Domain | Filamin | 2.69e-03 | 11 | 134 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 2.69e-03 | 11 | 134 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 2.69e-03 | 11 | 134 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 2.69e-03 | 11 | 134 | 2 | IPR017868 | |
| Domain | Adap_comp_sub | 2.69e-03 | 11 | 134 | 2 | PF00928 | |
| Domain | Laminin_G_1 | 2.69e-03 | 11 | 134 | 2 | PF00054 | |
| Domain | Serpin_fam | 2.73e-03 | 39 | 134 | 3 | IPR000215 | |
| Domain | LDLR_class-A_CS | 2.94e-03 | 40 | 134 | 3 | IPR023415 | |
| Domain | Laminin_G_2 | 2.94e-03 | 40 | 134 | 3 | PF02210 | |
| Domain | Clathrin_sm-chain_CS | 3.22e-03 | 12 | 134 | 2 | IPR000804 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 2.28e-06 | 120 | 101 | 8 | MM14982 | |
| Pathway | REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE | 1.95e-05 | 8 | 101 | 3 | M27375 | |
| Pathway | REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE | 1.95e-05 | 8 | 101 | 3 | MM15121 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | HIP1 MIA3 HEATR5A CUBN AP3M1 OPHN1 SLC27A1 AP3M2 LRP1 LRP6 MARCO | 8.75e-05 | 381 | 101 | 11 | M48063 |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 2.63e-04 | 124 | 101 | 6 | M27285 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 2.68e-04 | 80 | 101 | 5 | M6121 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | HSPG2 FLOT2 PCBP3 ANXA7 GAS6 CUBN ACTR3 DDT IGLV3-21 FCGBP PIGR SUSD2 TMEM132A SERPINC1 C4A C4B UPK2 SYTL1 DDTL CDH1 MUC4 SERPIND1 | 3.13e-10 | 1070 | 139 | 22 | 23533145 |
| Pubmed | IL12RB1 FLOT2 CTTNBP2 DOCK8 BCAS3 PCLO IQSEC2 NFASC WDR37 AP3M1 DDB1 SLC1A4 NDUFS1 ACTR3 TRIM3 OPHN1 CADPS SLC27A1 NAV1 C4A RIMBP2 C4B ATP1A3 WNK2 | 2.59e-09 | 1431 | 139 | 24 | 37142655 | |
| Pubmed | HSPG2 CFAP95 FCGBP PIGR SUSD2 LRP1 SERPINC1 C4A CDH5 MARCO SERPIND1 | 7.86e-09 | 257 | 139 | 11 | 16335952 | |
| Pubmed | GFPT2/GFAT2 and AMDHD2 act in tandem to control the hexosamine pathway. | 6.25e-08 | 3 | 139 | 3 | 35229715 | |
| Pubmed | 9.09e-07 | 44 | 139 | 5 | 31273033 | ||
| Pubmed | 1.32e-06 | 196 | 139 | 8 | 19334288 | ||
| Pubmed | 4.25e-06 | 105 | 139 | 6 | 30280653 | ||
| Pubmed | NCOA6 FLOT2 DDX51 GPKOW AP3M1 NDUFS1 GFPT1 EHBP1L1 GFPT2 CUX1 CDH17 ZNF687 | 1.05e-05 | 638 | 139 | 12 | 31182584 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 1.59e-05 | 2 | 139 | 2 | 16565498 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15998580 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18177725 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 19062096 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15609093 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 1.59e-05 | 2 | 139 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 1.59e-05 | 2 | 139 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 1.59e-05 | 2 | 139 | 2 | 17645767 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17828401 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 1.59e-05 | 2 | 139 | 2 | 27758680 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22387014 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 1.59e-05 | 2 | 139 | 2 | 23749435 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 1.59e-05 | 2 | 139 | 2 | 3037333 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 11726230 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 1.59e-05 | 2 | 139 | 2 | 6950384 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 1.59e-05 | 2 | 139 | 2 | 8428773 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 1.59e-05 | 2 | 139 | 2 | 21345967 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 2572548 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 2302180 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 1.59e-05 | 2 | 139 | 2 | 18091514 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 29080553 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 1.59e-05 | 2 | 139 | 2 | 25339671 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17728371 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 6149580 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 6149581 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12115608 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 3542363 | ||
| Pubmed | CAPS-1 and CAPS-2 are essential synaptic vesicle priming proteins. | 1.59e-05 | 2 | 139 | 2 | 18022372 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 2387317 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 16908004 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 7365238 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 7391573 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17971360 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17960519 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 1.59e-05 | 2 | 139 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 1.59e-05 | 2 | 139 | 2 | 17971229 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 28883501 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 6881182 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 1.59e-05 | 2 | 139 | 2 | 17921792 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 1.59e-05 | 2 | 139 | 2 | 6978711 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 35898513 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 28873507 | ||
| Pubmed | Iron Regulatory Protein 2 Exerts its Oncogenic Activities by Suppressing TAp63 Expression. | 1.59e-05 | 2 | 139 | 2 | 32276991 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 276882 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18648652 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 1.59e-05 | 2 | 139 | 2 | 6832377 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 3794341 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17360538 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 9858785 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22785613 | ||
| Pubmed | Distribution maps of D-dopachrome tautomerase in the mouse brain. | 1.59e-05 | 2 | 139 | 2 | 23000624 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 32691186 | ||
| Pubmed | Two distinct secretory vesicle-priming steps in adrenal chromaffin cells. | 1.59e-05 | 2 | 139 | 2 | 20855507 | |
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 1.59e-05 | 2 | 139 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 1.59e-05 | 2 | 139 | 2 | 3902619 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 34482436 | ||
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 1.59e-05 | 2 | 139 | 2 | 7373044 | |
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 1.59e-05 | 2 | 139 | 2 | 3696167 | |
| Pubmed | Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk. | 1.59e-05 | 2 | 139 | 2 | 26031789 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 1.59e-05 | 2 | 139 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 1.59e-05 | 2 | 139 | 2 | 16098595 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 1.59e-05 | 2 | 139 | 2 | 15787745 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 35235452 | ||
| Pubmed | CAPS facilitates filling of the rapidly releasable pool of large dense-core vesicles. | 1.59e-05 | 2 | 139 | 2 | 18495893 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 30026462 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 6559257 | ||
| Pubmed | Abnormal corneal endothelial maturation in collagen XII and XIV null mice. | 1.59e-05 | 2 | 139 | 2 | 23599329 | |
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 1.59e-05 | 2 | 139 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 1.59e-05 | 2 | 139 | 2 | 20506482 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12480675 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 26800705 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 1.59e-05 | 2 | 139 | 2 | 15390104 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 9060444 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 1.59e-05 | 2 | 139 | 2 | 1699796 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 1.59e-05 | 2 | 139 | 2 | 2997024 | |
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 1.59e-05 | 2 | 139 | 2 | 3624865 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 26149475 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21857912 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 1.59e-05 | 2 | 139 | 2 | 4514997 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 1.59e-05 | 2 | 139 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 1.59e-05 | 2 | 139 | 2 | 3167981 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 7545960 | ||
| GeneFamily | Fibronectin type III domain containing | IL12RB1 COL12A1 MYLK DSCAM NFASC PTPRH COL14A1 ROS1 USH2A EPHA10 | 4.41e-09 | 160 | 86 | 10 | 555 |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 5.90e-08 | 9 | 86 | 4 | 1234 | |
| GeneFamily | Serpin peptidase inhibitors | 7.18e-04 | 37 | 86 | 3 | 739 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.03e-03 | 161 | 86 | 5 | 593 | |
| GeneFamily | Low density lipoprotein receptors | 1.69e-03 | 13 | 86 | 2 | 634 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP | 8.63e-06 | 194 | 137 | 8 | M4181 | |
| Coexpression | GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP | 1.64e-05 | 153 | 137 | 7 | M438 | |
| Coexpression | GSE6259_DEC205_POS_DC_VS_CD8_TCELL_DN | 1.71e-05 | 154 | 137 | 7 | M6776 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000 | MYH8 COL12A1 SETX MYLK DOCK8 GSDMC GFPT1 OPHN1 ARG2 EHBP1L1 TP63 AHNAK KCNJ8 COL14A1 CDH1 CDH5 CUX1 ADSS1 | 2.30e-06 | 774 | 136 | 18 | gudmap_developingLowerUrinaryTract_P1_ureter_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_1000 | SEL1L MYLK ZNF560 BCAS3 GAS6 LRRK1 GSDMC SLC1A4 ARG2 EHBP1L1 CADPS PCNX4 AHNAK COL14A1 ANKMY2 CADPS2 CUX1 | 1.68e-05 | 809 | 136 | 17 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000 |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.45e-08 | 173 | 139 | 8 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-07 | 182 | 139 | 8 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.30e-07 | 186 | 139 | 8 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.60e-07 | 191 | 139 | 8 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 1.73e-07 | 193 | 139 | 8 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-07 | 194 | 139 | 8 | 0cd4363627acd419e00d6d32f6dce10430aa6487 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-07 | 194 | 139 | 8 | a58841b34efe673671a9a059238e044a7254b279 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.87e-07 | 195 | 139 | 8 | b9e8f405f6d837bb39b615836d3e2df349737c0e | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-07 | 196 | 139 | 8 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | distal-3-Epithelial-Differentiating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-07 | 196 | 139 | 8 | 77635a0f86910c4019d3370e9c8ba41de176bcf3 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-07 | 196 | 139 | 8 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 2.18e-07 | 199 | 139 | 8 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-07 | 199 | 139 | 8 | 2b357cc08c425a58d45aa6c086101c8fff53e218 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.27e-07 | 200 | 139 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.27e-07 | 200 | 139 | 8 | 21d9cf3cd3696ad6b745c7c036798f04b6ce5160 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.27e-07 | 200 | 139 | 8 | 33658d5d09e2eaff60f4dd88837d4252328eab63 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.27e-07 | 200 | 139 | 8 | d5426cd318a8f90c0bd8f9804351ab230fafc995 | |
| ToppCell | Club_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 7.57e-07 | 161 | 139 | 7 | bd08a23b415617f6e8748ed2668d578a860ecf91 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.27e-06 | 174 | 139 | 7 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-06 | 175 | 139 | 7 | af9c5104c86231cfdb93a0f7d7032379efaa009e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-06 | 175 | 139 | 7 | 4bfae78ac3a2cb9404382aae96d291504a9cfa14 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-06 | 177 | 139 | 7 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.48e-06 | 178 | 139 | 7 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 180 | 139 | 7 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | Control-Epithelial-Goblet|Control / Disease state, Lineage and Cell class | 1.60e-06 | 180 | 139 | 7 | 5293d23b8b8ea587239ffde561b70bad01632521 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-06 | 181 | 139 | 7 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.66e-06 | 181 | 139 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 183 | 139 | 7 | 26b18d1cc5d98f185176e100bafb9bc9081c66f7 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.92e-06 | 185 | 139 | 7 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-06 | 185 | 139 | 7 | edb114487206e4e8df4c7878285df40f49b7fd64 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.99e-06 | 186 | 139 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-06 | 189 | 139 | 7 | ee15b4fb3a1cfda80bcf210a23f04f242594015e | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-06 | 189 | 139 | 7 | dc6f6fae84347d145bea71b49eaeeb3028e9c4ae | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 2.21e-06 | 189 | 139 | 7 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 2.21e-06 | 189 | 139 | 7 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 2.29e-06 | 190 | 139 | 7 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-06 | 191 | 139 | 7 | 2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.37e-06 | 191 | 139 | 7 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 2.45e-06 | 192 | 139 | 7 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 2.45e-06 | 192 | 139 | 7 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.45e-06 | 192 | 139 | 7 | 2f1c4ef693515ccc7231bd8c6641fad51d445d20 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-06 | 192 | 139 | 7 | a42aed9e563f5f4af029b8804c104f11ad227a8f | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.45e-06 | 192 | 139 | 7 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.45e-06 | 192 | 139 | 7 | 011634a24b0c61d9b463fe755502edbc5cd70b7a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-06 | 123 | 139 | 6 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | Club_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.54e-06 | 193 | 139 | 7 | 6582c0367052b9d10fb629c383ee0c55872afd2d | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.54e-06 | 193 | 139 | 7 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | distal-Epithelial-Differentiating_Basal-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.72e-06 | 195 | 139 | 7 | 3fe6e49a9161fc9e5160251e6932cb5378175a54 | |
| ToppCell | Mesenchymal_cells|World / Lineage and Cell class | 2.72e-06 | 195 | 139 | 7 | 380eb436baa371f7aa2dc0c4a594afb173b5a25b | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-06 | 197 | 139 | 7 | 06ed8f293d4ee89f14dc2f43d6cae93bbc02508a | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-06 | 197 | 139 | 7 | c115d0a45545ed24259ad88872231bf4d4d389d2 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.00e-06 | 198 | 139 | 7 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.00e-06 | 198 | 139 | 7 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 3.00e-06 | 198 | 139 | 7 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-SCGB3A2+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.00e-06 | 198 | 139 | 7 | 1fe51f4beca0eef4ff117e6edaa646e35c0f9629 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 3.00e-06 | 198 | 139 | 7 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.00e-06 | 198 | 139 | 7 | 9895f1d65d18d939f3974a914ee41c6d5575e765 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.00e-06 | 198 | 139 | 7 | 58508a8df2714d769f137794c29441a7bd38b350 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.00e-06 | 198 | 139 | 7 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.10e-06 | 199 | 139 | 7 | a8bfc0b93ad9968cf52a25be86995ffe436bd636 | |
| ToppCell | proximal-Epithelial-Mucous-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.10e-06 | 199 | 139 | 7 | baac580484124b7c36717b607adcf2cb446e631d | |
| ToppCell | proximal-Epithelial-Mucous|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.10e-06 | 199 | 139 | 7 | 15ba36fa6ad73d0e959e42f18d7acbc14e310dc9 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 199 | 139 | 7 | 8649c2380285a668782d75eb076ce548eed0911d | |
| ToppCell | Biopsy_Other_PF-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.10e-06 | 199 | 139 | 7 | 036244251d2dd39f8184b7095418c723c0524eff | |
| ToppCell | proximal-3-Epithelial-Mucous|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.10e-06 | 199 | 139 | 7 | 3018378860de084662be0cc46fce421db3bb9ec9 | |
| ToppCell | distal-3-Epithelial-Mucous|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.10e-06 | 199 | 139 | 7 | 64dc8a9b25cd52935bd3f956b5c65d2fd1bf4bf5 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-06 | 200 | 139 | 7 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-06 | 200 | 139 | 7 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.21e-06 | 200 | 139 | 7 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | COVID|World / Condition, Cell_class and T cell subcluster | 3.21e-06 | 200 | 139 | 7 | 04a932fe2431e7886120c219ce666f90d3030a1c | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.38e-06 | 145 | 139 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Club_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.45e-06 | 149 | 139 | 6 | 81c813588bb5efb7b31141a75d387210dcb76094 | |
| ToppCell | 18-Airway-Epithelial-Goblet-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 8.67e-06 | 153 | 139 | 6 | 14a60220e169ce642771636de982a7b02e5b2608 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 160 | 139 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 160 | 139 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 161 | 139 | 6 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 161 | 139 | 6 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.24e-05 | 163 | 139 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.43e-05 | 167 | 139 | 6 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 169 | 139 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 170 | 139 | 6 | 03cb4e508356f85372a588c8d1c6babf2a012683 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-05 | 171 | 139 | 6 | fd59ac4a39748840b2ee1c930ea475433ff61485 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-05 | 171 | 139 | 6 | d5960b40ad5b87aaa00c93a6b31cdf41cc4f1375 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-05 | 171 | 139 | 6 | d382430e5cdd0f2aac4fc093d8fe8d66efb4629b | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-05 | 171 | 139 | 6 | 4347e6f62c04ea43299893ad4b79719049009a56 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-05 | 174 | 139 | 6 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-05 | 174 | 139 | 6 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 175 | 139 | 6 | 7329ebb135fc4311ee9595729b62a5d152c9de8c | |
| ToppCell | (03)_Secretory|World / shred by cell type and Timepoint | 1.92e-05 | 176 | 139 | 6 | cb7b1945788196ca79007f0768b6576ec885a0e5 | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.92e-05 | 176 | 139 | 6 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.98e-05 | 177 | 139 | 6 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.98e-05 | 177 | 139 | 6 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 178 | 139 | 6 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.11e-05 | 179 | 139 | 6 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.11e-05 | 179 | 139 | 6 | 5f7e6670a0e906a0a5bc75735408361d88e78fa2 | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-05 | 179 | 139 | 6 | ec331b1132f965581f851a3b29e62873c4140e6c | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.18e-05 | 180 | 139 | 6 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-05 | 180 | 139 | 6 | 7d3d5608647b6e684e8e185993d106a38c53e76a | |
| ToppCell | facs-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 180 | 139 | 6 | 72310baeed848f2c483ae986cd73d2fb2cca7feb | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.25e-05 | 181 | 139 | 6 | bab282cb0d9fc049f6fb094cf8b1fba104f4ea17 | |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.39e-06 | 199 | 137 | 9 | 4691_DN | |
| Drug | D-glucosamine-6P | 1.17e-05 | 8 | 137 | 3 | CID000121988 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.32e-05 | 179 | 137 | 8 | 1005_UP | |
| Drug | Glcnac6P | 1.44e-05 | 25 | 137 | 4 | CID000150941 | |
| Drug | S-2390 | 1.74e-05 | 9 | 137 | 3 | CID000192089 | |
| Drug | Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 2.35e-05 | 194 | 137 | 8 | 7468_DN | |
| Drug | Ronidazole [7681-76-7]; Up 200; 20uM; PC3; HT_HG-U133A | 2.53e-05 | 196 | 137 | 8 | 7131_UP | |
| Drug | monatepil | 2.65e-05 | 29 | 137 | 4 | CID000060810 | |
| Drug | Novobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; PC3; HT_HG-U133A | 2.72e-05 | 198 | 137 | 8 | 4569_DN | |
| Drug | Oxaprozin [21256-18-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.72e-05 | 198 | 137 | 8 | 3876_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.82e-05 | 199 | 137 | 8 | 4526_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 2.93e-05 | 200 | 137 | 8 | 5570_UP | |
| Drug | Ardeparin | 3.59e-05 | 2 | 137 | 2 | DB00407 | |
| Drug | Sch 37137 | 3.59e-05 | 2 | 137 | 2 | CID000197244 | |
| Drug | Sulodexide | 3.59e-05 | 2 | 137 | 2 | DB06271 | |
| Drug | Lys-Nva-FMDP | 3.59e-05 | 2 | 137 | 2 | CID006475796 | |
| Drug | FMDP-Val | 3.59e-05 | 2 | 137 | 2 | CID006475745 | |
| Drug | A-E-C | 6.48e-05 | 70 | 137 | 5 | CID006438040 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 1.00e-04 | 177 | 137 | 7 | 6943_UP | |
| Drug | 3-amino-3-deoxy-D-glucose | 1.07e-04 | 3 | 137 | 2 | CID000164683 | |
| Drug | Uranium pentafluoride | 1.07e-04 | 3 | 137 | 2 | CID003014661 | |
| Drug | 2-aminothiophenol | 1.07e-04 | 3 | 137 | 2 | ctd:C005464 | |
| Drug | 5 PA | 1.07e-04 | 3 | 137 | 2 | CID000004324 | |
| Drug | kanosamine-6-phosphate | 1.07e-04 | 3 | 137 | 2 | CID000443710 | |
| Drug | Avl-FMDP | 1.07e-04 | 3 | 137 | 2 | CID006473933 | |
| Drug | C4 m | 1.16e-04 | 79 | 137 | 5 | CID009543487 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.19e-04 | 182 | 137 | 7 | 998_UP | |
| Drug | Aspidium | 1.28e-04 | 184 | 137 | 7 | CID000000815 | |
| Drug | quinocetone | 1.32e-04 | 248 | 137 | 8 | ctd:C502851 | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.71e-04 | 193 | 137 | 7 | 4690_DN | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; HL60; HT_HG-U133A | 1.77e-04 | 194 | 137 | 7 | 2180_UP | |
| Drug | Ethionamide [536-33-4]; Down 200; 24uM; HL60; HT_HG-U133A | 1.77e-04 | 194 | 137 | 7 | 2495_DN | |
| Drug | 17-DMAG; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.77e-04 | 194 | 137 | 7 | 1213_UP | |
| Drug | Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.83e-04 | 195 | 137 | 7 | 7368_DN | |
| Drug | Amoxicillin [26787-78-0]; Down 200; 11uM; PC3; HT_HG-U133A | 1.83e-04 | 195 | 137 | 7 | 6285_DN | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.89e-04 | 196 | 137 | 7 | 2072_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A | 1.89e-04 | 196 | 137 | 7 | 3732_UP | |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; PC3; HT_HG-U133A | 1.89e-04 | 196 | 137 | 7 | 4567_UP | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A | 1.89e-04 | 196 | 137 | 7 | 1511_DN | |
| Drug | Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.89e-04 | 196 | 137 | 7 | 4718_DN | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Up 200; 12.4uM; PC3; HT_HG-U133A | 1.89e-04 | 196 | 137 | 7 | 6740_UP | |
| Drug | phosphoribosylamine | 1.92e-04 | 19 | 137 | 3 | CID000000150 | |
| Drug | Pindolol [13523-86-9]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.95e-04 | 197 | 137 | 7 | 2075_UP | |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; HL60; HT_HG-U133A | 1.95e-04 | 197 | 137 | 7 | 2350_UP | |
| Drug | Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A | 1.95e-04 | 197 | 137 | 7 | 3798_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 1.95e-04 | 197 | 137 | 7 | 3870_DN | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A | 1.95e-04 | 197 | 137 | 7 | 6663_DN | |
| Drug | Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 5409_UP | |
| Drug | Hecogenin [467-55-0]; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 5818_UP | |
| Drug | Isoniazid [54-85-3]; Up 200; 29.2uM; PC3; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 2083_UP | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 7391_UP | |
| Drug | Benzthiazide [91-33-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 4952_UP | |
| Drug | Phensuximide [86-34-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 3521_UP | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; PC3; HT_HG-U133A | 2.01e-04 | 198 | 137 | 7 | 4320_UP | |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; HL60; HG-U133A | 2.01e-04 | 198 | 137 | 7 | 2010_DN | |
| Drug | Trifluridine [70-00-8]; Up 200; 13.6uM; HL60; HT_HG-U133A | 2.07e-04 | 199 | 137 | 7 | 6136_UP | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 2.07e-04 | 199 | 137 | 7 | 7234_UP | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; HL60; HT_HG-U133A | 2.07e-04 | 199 | 137 | 7 | 1337_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; HL60; HT_HG-U133A | 2.07e-04 | 199 | 137 | 7 | 2545_UP | |
| Drug | Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.07e-04 | 199 | 137 | 7 | 4946_UP | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 2.13e-04 | 200 | 137 | 7 | 5931_DN | |
| Drug | Gabazine [105538-73-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.13e-04 | 200 | 137 | 7 | 4820_UP | |
| Drug | Noscapine [128-62-1]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.13e-04 | 200 | 137 | 7 | 5851_UP | |
| Drug | Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 2.13e-04 | 200 | 137 | 7 | 7261_DN | |
| Drug | AC1O5Y0I | 2.14e-04 | 4 | 137 | 2 | CID006442853 | |
| Drug | 2-amino-2-deoxy-D-glucitol 6-phosphate | 2.14e-04 | 4 | 137 | 2 | CID000001554 | |
| Drug | naroparcil | 2.14e-04 | 4 | 137 | 2 | CID003047782 | |
| Drug | AC1LANBP | 2.14e-04 | 4 | 137 | 2 | CID000516790 | |
| Disease | thanatophoric dysplasia (implicated_via_orthology) | 2.14e-05 | 2 | 137 | 2 | DOID:13481 (implicated_via_orthology) | |
| Disease | hyperinsulinism (biomarker_via_orthology) | 4.28e-05 | 15 | 137 | 3 | DOID:2018 (biomarker_via_orthology) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy type 2H (implicated_via_orthology) | 6.40e-05 | 3 | 137 | 2 | DOID:0110282 (implicated_via_orthology) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (implicated_via_orthology) | 6.40e-05 | 3 | 137 | 2 | DOID:0110274 (implicated_via_orthology) | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 8.98e-05 | 19 | 137 | 3 | DOID:1168 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | CPAMD8 ZNF560 AMDHD2 CUBN CSMD3 TP63 LRP1 FGFR3 CDH1 CDH5 CUX1 CCDC93 | 1.11e-04 | 702 | 137 | 12 | C0009402 |
| Disease | Machado-Joseph disease (implicated_via_orthology) | 1.28e-04 | 4 | 137 | 2 | DOID:1440 (implicated_via_orthology) | |
| Disease | Venous Thromboembolism | 5.88e-04 | 8 | 137 | 2 | C1861172 | |
| Disease | Osteitis Deformans | 7.54e-04 | 9 | 137 | 2 | C0029401 | |
| Disease | Glaucoma | 7.54e-04 | 9 | 137 | 2 | C0017601 | |
| Disease | Cleft palate with cleft lip | 7.54e-04 | 9 | 137 | 2 | C0158646 | |
| Disease | Congenital myasthenic syndrome | 9.40e-04 | 10 | 137 | 2 | cv:C0751882 | |
| Disease | epilepsy (implicated_via_orthology) | 1.01e-03 | 163 | 137 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | receptive language perception, parental genotype effect measurement | 1.88e-03 | 14 | 137 | 2 | EFO_0005686, EFO_0005939 | |
| Disease | precuneus cortex volume measurement | 1.88e-03 | 14 | 137 | 2 | EFO_0010326 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 2.46e-03 | 16 | 137 | 2 | C0751885 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 2.78e-03 | 17 | 137 | 2 | C0751883 | |
| Disease | caudal middle frontal gyrus volume measurement | 3.12e-03 | 18 | 137 | 2 | EFO_0010290 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 3.47e-03 | 19 | 137 | 2 | C0751884 | |
| Disease | cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant | 3.47e-03 | 19 | 137 | 2 | EFO_0007044, EFO_0020106 | |
| Disease | superior temporal gyrus volume measurement | 3.47e-03 | 19 | 137 | 2 | EFO_0010331 | |
| Disease | Neoplasm Metastasis | 3.50e-03 | 217 | 137 | 5 | C0027627 | |
| Disease | essential tremor | 3.78e-03 | 136 | 137 | 4 | EFO_0003108 | |
| Disease | skin pigmentation measurement | 3.88e-03 | 137 | 137 | 4 | EFO_0007009 | |
| Disease | renal cell carcinoma (is_implicated_in) | 4.10e-03 | 69 | 137 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | muscular dystrophy (implicated_via_orthology) | 4.24e-03 | 21 | 137 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 4.24e-03 | 21 | 137 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RSDQVTGAVTTVGVA | 126 | Q9NWW9 | |
| EISGINIVAGSRVSS | 626 | Q8N1M1 | |
| DTLAVAVENGTGTDR | 381 | Q9H0X4 | |
| RGTTIANVVSNSVGT | 111 | Q9BQE5 | |
| ATQVSDSGVIALVSG | 176 | Q8IY45 | |
| VDVIASSFGQTREGG | 316 | P78540 | |
| EVRSGSSETSTVIGR | 2166 | Q7Z407 | |
| TTEERGLNVTLSSTG | 1321 | P0C0L5 | |
| GSEGNITTRIRASET | 651 | P39880 | |
| VVQSGRSEAGVDRIS | 106 | Q8IYS8 | |
| GVNVGIEVSVSGEAS | 96 | Q9BYG8 | |
| TAEGVALTVTGVAQV | 61 | Q14254 | |
| ATVVEEGTGVEANAT | 316 | A8K2U0 | |
| EEEGAVSTRGTSVQS | 171 | Q8WYK0 | |
| GDLGETQSRTITVTR | 141 | Q09666 | |
| GAGTDDSTLVRIVVT | 431 | P20073 | |
| RSVLGSENGVTSLTV | 216 | Q8TAP6 | |
| RSVVNSITGSSNVGD | 141 | Q9Y2T2 | |
| GSEAAASTAVVIAGR | 411 | P01008 | |
| DRRGVSTVIDAASGT | 811 | Q9H6U6 | |
| RGDSGTATVLVTLQD | 236 | P33151 | |
| TAGIGTSVIVVQATD | 1221 | Q9H251 | |
| DINSSTGVVTVRSGV | 2011 | Q9H251 | |
| SISSIGVVGTAEDNR | 61 | A6NHG4 | |
| SGDTVSGRVNLEVTG | 26 | Q96B67 | |
| VQVTGRRISATAEDG | 66 | O60258 | |
| VGSSGTQEASVLVTI | 2506 | P98160 | |
| AGSRETSLIVTIQGS | 2606 | P98160 | |
| EATERVQGGRTVTTV | 181 | Q9Y644 | |
| FGSGVSQLSIVDRTT | 356 | P48200 | |
| GNAGEITSSVVASRT | 766 | O60890 | |
| GTITVNEEGTQATTV | 441 | P05546 | |
| NEETVSSGIIERVTG | 116 | Q5VTT2 | |
| RTVVNTITGSTNVGD | 141 | P53677 | |
| RLTVEEATASVSEGG | 1321 | Q9ULU8 | |
| GTTVTLTISGVQAED | 86 | P01717 | |
| TSAVSITAGQEGQSR | 166 | Q99102 | |
| IASGTSEQTRAVVEG | 141 | A9QM74 | |
| GSGARQVTVELTVEG | 111 | Q15746 | |
| LEGVVETTGITTQAR | 296 | Q15842 | |
| REVQVSGTSEVSAGP | 51 | Q5VVH5 | |
| VTSVVCSSEGRGEEV | 1736 | Q38SD2 | |
| RAFINGTGVETVVSA | 1641 | Q07954 | |
| DGSGSVVLRNSTTLV | 1816 | Q07954 | |
| TGGSEGVVRSDQVII | 71 | A0A0K2S4Q6 | |
| TGQAVVGSDITSITE | 226 | Q53G44 | |
| RNSVGSLDSTIEGSV | 1156 | Q5JU85 | |
| VESRSLQNGASITGT | 736 | Q8NCM2 | |
| TEGGATLTVREDQVF | 66 | P13535 | |
| STVSQGITDGEVVDL | 2886 | Q9Y6V0 | |
| TAVDLTSGRVTTGEV | 3021 | Q9Y6V0 | |
| SVESQRVGDHSTGTV | 856 | Q63HM2 | |
| SSAGVIVTSGQSARV | 2491 | Q7Z5P9 | |
| VTSGQSARVTETVGA | 2646 | Q7Z5P9 | |
| SARVTETVGASAGVT | 2651 | Q7Z5P9 | |
| VRGTETTGQSAAESV | 3131 | Q7Z5P9 | |
| AEVTEITGISAVVTG | 3491 | Q7Z5P9 | |
| LANTTGTVTASEVGI | 536 | A2RU67 | |
| SISSIGVVGTAEDNR | 61 | P30046 | |
| TEILGTQEIASRSSG | 816 | Q8N3D4 | |
| AQTSGVQEAETRVGS | 881 | Q8N3D4 | |
| DTGTDRIEVTRLNGT | 421 | O75581 | |
| GNTATLTISRVEAGD | 86 | P80748 | |
| TDTGALADGVVSQAV | 91 | Q92917 | |
| SIEVQTLGEAASGSR | 546 | Q5JZY3 | |
| VVFGTSGSEVQRGDI | 341 | Q8NBF2 | |
| NATEGSSERQITITG | 331 | P57721 | |
| STVSVAAVGGVVEDN | 1401 | Q14686 | |
| TLSARTQVGSGEAVT | 1006 | O94856 | |
| VSVGSSETRGERVID | 626 | Q9H3D4 | |
| VSGVVVESENERAGT | 2231 | Q8NFC6 | |
| AVVRFVTDGSVTASG | 2426 | O60494 | |
| EESRLTASSVGQIVG | 266 | Q567U6 | |
| RQVGERTLTGTVIDS | 156 | P61158 | |
| GTSSVSRDVRVGVTQ | 291 | Q86XA9 | |
| VTDVDSVVGRSSVGE | 421 | Q8NF50 | |
| GVTNTVGSSISRETD | 446 | O94808 | |
| VAGGETQEVTVRGDT | 851 | Q99715 | |
| DGTRGQEITVRGSET | 2241 | Q99715 | |
| VSISVGTEGTVTRSV | 291 | Q8WZ74 | |
| GTEGTVTRSVACQTD | 296 | Q8WZ74 | |
| STDATARGIDVQGVE | 561 | Q8N8A6 | |
| VSVADGRISVTQGAS | 2966 | Q9Y6R7 | |
| DVGTGSVRAALVDQS | 16 | Q96C11 | |
| TGIRNLVVGDETTSS | 736 | Q05707 | |
| ATLEVDGTRGQSEVS | 586 | Q14393 | |
| VTVDGRGASVFIQTD | 121 | Q8IZJ3 | |
| ASVTREEVVSELGNG | 256 | Q9NX46 | |
| EAGAETDVVNSVGRT | 101 | Q8IV38 | |
| RLTVEEATASVSEGG | 1266 | Q86UW7 | |
| ASATVATVGQGISNV | 96 | Q9NRY5 | |
| ERGENSVSVRIVGSS | 416 | Q9UEW3 | |
| TETQVTLSGLRAGVA | 501 | P42701 | |
| EGTARGVVVATGDRT | 241 | P13637 | |
| EAVTGITVSRNGSSV | 631 | Q92636 | |
| IVAGASSESLGTEQR | 16 | P22607 | |
| SSESLGTEQRVVGRA | 21 | P22607 | |
| QVVATEVGGSSLSSV | 636 | Q12864 | |
| LSSRIEVQDTSGGTT | 736 | Q16531 | |
| QGEGLSTTATAVITV | 351 | P12830 | |
| TTEERGLNVTLSSTG | 1321 | P0C0L4 | |
| VERSGREVTEGIVST | 1576 | Q8NEY1 | |
| VVAVTSAGRGNSSEI | 1261 | O60469 | |
| GSSQAGVVTVSDVQE | 11 | O00233 | |
| AETVSTQVGTEGGLR | 36 | Q8IZ73 | |
| NSGSAEERSEAIIVG | 31 | Q9GZV3 | |
| SLSGDAEAVQVRGSV | 256 | Q8IYJ3 | |
| GAVVNLASVSSGAVR | 1871 | O75445 | |
| GVTVRTLSAQGESVD | 561 | O15034 | |
| TETRGTGLTAVAVQE | 496 | Q9UGT4 | |
| AAATGSRVTVVLGAQ | 26 | Q8N142 | |
| FVVENSTGGGVAVTR | 351 | Q24JP5 | |
| ASDISLTGGSVVQRI | 326 | Q9UBV2 | |
| TIFSIVTGGEETRDT | 386 | Q5JRA6 | |
| TVGITNTVGSSISRE | 461 | Q06210 | |
| GTTVTLTISGAQVED | 86 | P01718 | |
| EVRDLGSTGTSSVQR | 1151 | Q8N4C6 | |
| AVGSNIVVSTRTGEV | 256 | P28331 | |
| ASGAGEAEERVVVIS | 546 | P29590 | |
| GVNQATAGVVASTIS | 941 | O00291 | |
| NVVSDERRVSSSGGL | 151 | Q9UK23 | |
| GDTSRGQVIIISDSD | 1006 | Q7Z333 | |
| VTGANAEDTTETGRQ | 206 | P21815 | |
| EVTLGASVRASSGSV | 1046 | Q6ZUB1 | |
| GTQAAAATGAVVSER | 356 | Q96P63 | |
| STVVIGNGTACRETE | 591 | Q8N5C6 | |
| GRQSIALSTVETGTV | 6 | O43868 | |
| FEVSIVDSGVRGTIA | 81 | Q8NCJ5 | |
| TVTERLGSSQFGTIV | 121 | A8MXK1 | |
| GENVSTTEVEGVLSR | 516 | Q6PCB7 | |
| DRTTTVVNVEGDALG | 456 | P43007 | |
| VATASTSIREDLVGG | 6 | Q8N801 | |
| VVGASDGIIRVFTES | 286 | Q9Y263 | |
| RDNSIVIVVGETGSG | 546 | Q92620 | |
| VLRGQSTGDTTITEF | 861 | P08922 | |
| EEQGGSSRALVSTLV | 631 | P01833 | |
| TVGDNVVSGSDDRTV | 376 | Q9Y2I8 | |
| LVSVVDSGAGFTVTR | 86 | O00526 | |
| GGTVISRTQSSLVEA | 486 | Q8N1G0 | |
| VEGVSQVRTAESGLF | 71 | Q9HCX3 | |
| EAVVSAVSEAGASGI | 576 | O94901 | |
| RRAQTASSIEVGVGE | 1826 | Q9Y3S1 | |
| SETVATGEGLRQTII | 326 | Q9C040 | |
| SGVRRLETSEGTSAQ | 26 | Q7L8A9 | |
| TRNTTATNVTVDGLG | 76 | Q9HD43 | |
| ENDSGTLDTVGAVVV | 226 | Q9H6P5 | |
| TSSGVIEDRRSNTGQ | 471 | Q96MR9 | |
| TRSIAETTQVGGSVS | 421 | B1APH4 | |
| GVSAASSGRIVVADS | 491 | O75382 | |
| SITVTTVASAGNIGE | 36 | Q7Z7D3 | |
| SQATEDVGSGVALVA | 81 | Q9Y303 |